SWS HEMODIALYSIS CARE CO., LTD. SWS Hemodialysis Care Co., Ltd. Stock
Equities
688410
CNE100005VK9
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.26 CNY | +1.00% |
|
-5.94% | -20.34% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 1B 139M | Sales 2025 * | 1.31B 182M | Capitalization | 4.99B 691M |
|---|---|---|---|---|---|
| Net income 2024 * | 244M 33.78M | Net income 2025 * | 302M 41.81M | EV / Sales 2024 * | 4.98 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.8 x |
| P/E ratio 2024 * |
20.6
x | P/E ratio 2025 * |
16.6
x | Employees | 732 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 33.48% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.00% | ||
| 1 week | -5.94% | ||
| Current month | -4.12% | ||
| 1 month | +4.16% | ||
| 3 months | -7.11% | ||
| 6 months | -22.21% | ||
| Current year | -20.34% |
1 week
22.84
24.28
1 month
21.8226.55
Current year
20.3630.81
1 year
20.3641.62
3 years
16.7942.23
5 years
16.7942.23
10 years
16.7942.23
| Managers | Title | Age | Since |
|---|---|---|---|
Guang Yong Gao
CEO | Chief Executive Officer | 55 | 01-03-25 |
Shang Ling Yu
DFI | Director of Finance/CFO | 49 | 04-06-30 |
Jin Tong
BRD | Director/Board Member | 42 | 06-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Feng Jiang
BRD | Director/Board Member | 61 | 23-04-23 |
Guang Yong Gao
CEO | Chief Executive Officer | 55 | 01-03-25 |
Shang Ling Yu
DFI | Director of Finance/CFO | 49 | 04-06-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 23.26 | +1.00% | 676 014 |
| 24-05-16 | 23.03 | -1.12% | 1,097,221 |
| 24-05-15 | 23.29 | -1.44% | 814,896 |
| 24-05-14 | 23.63 | -1.01% | 1,122,088 |
| 24-05-13 | 23.87 | -1.36% | 1,046,035 |
End-of-day quote Shanghai S.E., May 16, 2024
More quotes
SWS Hemodialysis Care Co Ltd is a China-based company specializing in the research, development, production and sales of blood purification equipment and consumables. The Company's main products and services include blood purification equipment, blood purification consumables, and chain hemodialysis center medical services. The blood purification equipment includes continuous blood purification equipment, hemodialysis machines, hemoperfusion machines and others. The blood purification consumables include self-branded and distributed brands of dialysate filters, hemodialyzers and others. The chain hemodialysis center medical services provide hemodialysis medical services for patients with kidney diseases.
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
23.26
CNY
Average target price
35
CNY
Spread / Average Target
+50.47%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -20.34% | 684M | |
| +12.15% | 228B | |
| +14.90% | 196B | |
| +18.22% | 141B | |
| +29.15% | 110B | |
| +0.53% | 65.88B | |
| +16.92% | 54.3B | |
| +6.33% | 52.39B | |
| +10.93% | 45.22B | |
| +5.87% | 37.12B |
- Stock Market
- Equities
- 688410 Stock
